Clinical considerations for patients with diabetes in times of COVID-19 pandemic

Diabetes Metab Syndr. 2020 Jul-Aug;14(4):451-453. doi: 10.1016/j.dsx.2020.03.005. Epub 2020 Mar 16.

Authors

Akhtar Hussain¹, Nayla Cristina do Vale Moreira²

Affiliations

¹ Fculty of Health Sciences, NORD University, Norway; Faculty of Medicine, Federal University of Ceará (FAMED-UFC), Brazil. International Diabetes Federation (IDF). Diabetes Asian Study Group (DASG). Electronic address: hussain.akhtar@nord.no.
² University of Oslo, Norway; Faculty of Medicine, Federal University of Ceará (FAMED-UFC), Brazil.

No abstract available

Publication types

Letter

MeSH terms

Betacoronavirus / pathogenicity*
COVID-19
Coronavirus Infections / epidemiology*
Coronavirus Infections / transmission
Coronavirus Infections / virology
Diabetes Mellitus / epidemiology
Diabetes Mellitus / physiopathology*
Diabetes Mellitus / virology
Global Health
Humans
Incidence
Pandemics
Pneumonia, Viral / epidemiology*
Pneumonia, Viral / transmission
Pneumonia, Viral / virology
SARS-CoV-2
Severity of Illness Index*